首页行业分类医疗医药创新药2023-04-27-西南证券-海思科-环泊酚持续高速增长,创新药有望密集兑现
PDF

2023-04-27-西南证券-海思科-环泊酚持续高速增长,创新药有望密集兑现

杰***痔4页1.01M

下载文档
/4
全屏查看
2023-04-27-西南证券-海思科-环泊酚持续高速增长,创新药有望密集兑现
还有 4 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 4 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
海思科(002653)2022年年报点评2022A2023E2024E2025E2022A2023E2024E2025E3015.293724.974503.705326.69391.64489.15665.33849.76营业成本919.281102.351272.231448.84折旧与摊销180.05252.54262.74273.39营业税金及册加35.8247.6849.5458.5943.131.981.641.89销售货用1136.161389.411679.881970.87-5.990.000.000.00327.71413.47504.41596.59经营营运黄本变动-339.46162.00-186.13.145.48财务货用43.131.981.641.89其他-174.83-20.87-24.16-16.030.000.000.0094.55884.80719.42963.52227.720.000.000.00.492.55-116.66-107.43-112.050.0020.0020.0020.0047.3320.0020.0020.00其他经营损益0.000.000.000.00-539.88-96.66-87.43-92.05364.44510.07696.00889.90短期借款32.51278.20-206.490.00217-1.30-0.79-0.47859.050.000.000.00366.61508.76695.21889.432.120.000.000.00所得税-25.0319.6129.8839.68支付股利-199.19-159.90-212.44-277.70391.64489.15665.33849.7670.26380.44-1.64-1.89114.64121.14184.26229.27624.23-818.54-420.56-279.59277.00368.01481.06620.48195.84-30.40211.42591.892022A2023E2024E2025E2022A2023E2024E2025E货币黄金775.39744.99956.421548.31成长能力应收和预付款项862.03906.811137.211351.96873%23.54%20.91%18.27%存货346.00348.58426.32488.07营业利润增长率-28.86%39.96%36.45%27.86%其他流动黄产70.2210.6212.8415.18-24.33%24.90%36.02%27.72%185.11185.11185.11185.11田TDA增长率-14.22%30.12%25.61%21.32%203.16203.16203.16203.161061.51906.46751.41596.36毛利率69.51%70.41%71.75%72.80%无彩资产和开发支出1939.541958.921958.881952.8049.98%48.45%48.54%48.24%603.00602.78602.56602.3412.99%13.13%14.77%15.95%6045.965867.426233.916943.30ROE12.50%14.45%17.33%19.26%484.69206.490.000.00ROA6.48%8.34%10.67%12.24%400.43520.27589.43673.82ROIC11.81%11.98%16.25%19.94%长期借款1311.461311.461311.461311.4619.49%20.53%21.32%21.87%715.96442.95493.86546.802912.532481.162394.752532.090.550.630.740.81股本1075.611114.121114.121114.123.034.206.169.25100.8262.3162.3162.314.814.965.175.011807.352015.462284.092626.87存货周转率2.973.103.253.153035.743167.453436.073778.86100.02%97.68218.82403.08632.363133.423386.273839.164411.2248.17%42.29%38.41%36.47%6045.965867.426233.916943.30带息债务感负债61.67%61.18%54.76%51.79%流动比率1.381.902.613.072022A2023E2024E2025E速动比率1.151.572.172.63EBITDA587.63764.59960.381165.18股利支付率71.91%43.45%44.16%44.76%PE110.4583.1363.6049.3110.089.668.908.100.250.330.430.56PS10.158.216.795.742.722.843.083.39EV/EBITDA50.4639.4430.9725.01每股经营现金0.080.790.650.860.65%0.52%0.69%0.91%每股股利0.180.140.190.25请务必阅读正文后的重要声明部分